Utility of Positron Emission Tomography in the Mediastinum: Moving Beyond Lung and Esophageal Cancer Staging

Thoracic Surgery Clinics

Volumn 19, Issue 1, 2009, Pages 7-15

  Puri, Varun ^a   Meyers, Bryan F ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Germ cell tumor; Lymphoma; Mediastinum; PET; Thymoma

Indexed keywords

BLEOMYCIN; CARBON 11; DACARBAZINE; DIAZEPAM; DOXORUBICIN; FENTANYL; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; NITROGEN 13; OXYGEN 15; RUBIDIUM 82; VINBLASTINE;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EVALUATION; COLORECTAL CANCER; DIAGNOSTIC VALUE; DRUG HALF LIFE; DRUG UPTAKE; ESOPHAGUS CANCER; GERM CELL TUMOR; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHOMA; MEDIASTINUM; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PARATHYROID ADENOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TUMOR DIAGNOSIS;

FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA; MEDIASTINUM; NEOPLASM STAGING; PARATHYROID NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THORACIC NEOPLASMS;

EID: 58149485056     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2008.09.006     Document Type: Review

References (34)

1. Podoloff D.A., Advani R.J., Allred C., et al. NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw 5 2 (2007) S1-S22
2. Blodgett T.M., Meltzer C.C., and Townsend D.W. PET/CT: form and function. Radiology 242 2 (2007) 360-385
3. Judenhofer M.S., Wehrl H.F., Newport D.F., et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 14 4 (2008) 459-465
4. Facey K., Bradbury I., Laking G., et al. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess 11 44 (2007) 1-285
5. Gould M.K., Maclean C.C., Kuschner W.G., et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285 7 (2001) 914-924
6. Meyers B.F., Downey R.J., Decker P.A., et al. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 133 3 (2007) 738-745
7. Raymond D.P., and Daniel T.M. Mediastinal anatomy and mediastinoscopy. In: Selke F.W., delNido P.J., and Swanson S.J. (Eds). Sabiston and Spencer surgery of the chest. 7th edition (2005), Elsevier Saunders, Philadelphia 657-666
8. Patel P.M., Alibazoglu H., Ali A., et al. Normal thymic uptake of FDG on PET imaging. Clin Nucl Med 21 10 (1996) 772-775
9. Nakahara T., Fujii H., Ide M., et al. FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT. Br J Radiol 74 885 (2001) 821-824
10. Brink I., Reinhardt M.J., Hoegerle S., et al. Increased metabolic activity in the thymus studied with FDG PET: age dependency and frequency after chemotherapy. J Nucl Med 42 4 (2001) 591-595
11. Fernidand B., Gupta P., and Kramer E.L. Spectrum of thymic uptake at 18F-FDG PET. Radiographics 24 6 (2004) 1611-1616
12. Liu R.S., Yeh S.H., Huang M.H., et al. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report. Eur J Nucl Med 22 12 (1995) 1402-1407
13. El-Bawab H., Al-Sugair A.A., Rafay M., et al. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology. Eur J Cardiothorac Surg 31 4 (2007) 731-736
14. Sasaki M., Kuwabara Y., Ichiya Y., et al. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET. J Nucl Med 40 10 (1999) 1595-1601
15. Kubota K., Yamada S., Kondo T., et al. PET imaging of primary mediastinal tumours. Br J Cancer 73 7 (1996) 882-886
16. Juweid M.E., Stroobnts S., Hoekstra O.S., et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma. J Clin Oncol 25 5 (2007) 571-578
17. Juweid M.E., Wiseman M.E., Vose J.M., et al. Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol 23 21 (2005) 4652-4661
18. Cheson B.D., Pfistner B., Juweid M.E., et al. Revised response criteria for malignant lymphoma. J Clin Oncol 25 5 (2007) 579-586
19. Zinzani P.L., Tani M., Trisolini R., et al. Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. Haematologica 92 6 (2007) 771-777
20. deSantis M., Becherer A., Bokemeyer C., et al. 18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 22 6 (2004) 1034-1039
21. Hain S., O'Doherty M., Timothy A., et al. Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med 27 5 (2000) 590-594
22. Kollmannsberger C., Oeschle K., Dohmen B., et al. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma. Cancer 94 9 (2002) 2353-2362
23. Bachman J., Ernestus K., Werner T., et al. Detection of primary choriocarcinoma in the mediastinum by F-18 FDG positron emission tomography. Clin Nucl Med 32 8 (2007) 663-665
24. Aide N. Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence?. J Clin Oncol 25 28 (2007) 4494-4496
25. Nilubol N., Beyer T., Prinz R.A., et al. Mediastinal hyperfunctioning parathyroids: incidence, evolving treatment, and outcome. Am J Surg 194 1 (2007) 53-56
26. Beggs A.D., and Hain S.F. Localization of parathyroid adenomas using 11C-methionine positron emission tomography. Nucl Med Commun 26 2 (2005) 133-136
27. Mackie G.C., and Pohlen J.M. Mediastinal histoplasmosis: F-18 FDG PET and CT findings simulating malignant disease. Clin Nucl Med 30 9 (2005) 633-635
28. Kim Y.K., Lee K.S., Kim B.T., et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer 109 6 (2007) 1068-1077
29. Nishiyama Y., Yamamoto Y., Fukunaga K., et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 47 10 (2006) 1571-1576
30. Truong M.T., Erasmus J.J., Munden R.F., et al. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. Am J Roentgenol 183 4 (2004) 1127-1132
31. Gelfand M.J., O'hara S.M., Curtwright L.A., et al. Premedication to block [(18)F]FDG uptake in the brown adipose tissue of pediatric and adolescent patients. Pediatr Radiol 35 10 (2005) 984-990
32. Watanabe H., Shinozaki T., Aoki J., et al. Glucose metabolic analysis of musculoskeletal tumors using fluorine-18-FDG PET as an aid in preoperative planning. J Bone Joint Surg Br 82 5 (2000) 760-767
33. Ahmed A.R., Watanabe H., Aoki J., et al. Schwannoma of the extremities: the role of PET in preoperative planning. Eur J Nucl Med 28 10 (2001) 1541-1551
34. Beaulieu S., Rubin B., Djang D., et al. Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning. Am J Roentgenol 182 4 (2004) 971-974